Autologous Hematopoietic Stem Cell Transplantation for Hematological Malignancies and Solid Tumors
10.3321/j.issn:1000-467X.2001.04.013
- VernacularTitle:自体造血干细胞移植治疗恶性血液病和恶性实体肿瘤
- Author:
Zhi-Xin SUN
1
;
Lin-Jun CHEN
;
Jun MA
;
Wen-Yi CHEN
;
Pei ZONG
;
Jing CAO
Author Information
1. Shanghai Changning District Central Hospital
- From:Chinese Journal of Cancer
2001;20(4):399-402
- CountryChina
- Language:Chinese
-
Abstract:
Objective： This study was designed to observe the efficacy and side effects of autologous hematopoietic stem cell transplantation (AHSCT) in the treatment of hematological malignancies and solid tumors. Methods： In the 7 patients, two received autologous bone marrow transplantation (ABMT) and five received autologous peripheral blood stem cell transplantation (APBSCT). The conditioning regimen consisted of VCCA (Vincristine, Me-CCNU, Ara-C, CTX) and TLI(total lymph irradiation) for malignant lymphoma, VCCED (VCR, Me-CCNU, CTX, Vp-16, DNR) and TBI for acute myeloid leukemia-M4, VCCME (VCR, Me-CCNU, CTX, Mitoxantron,Vp-16) for breast cancer. All harvests of stem cells were stored at 4℃ except one at -80℃ ,than transfused back to the patients within 72 hours without purgation. Results： The number of mononuclear cells and CD34＋ cells in harvest in APBSCT patients was (7.45± 5.89)× 108/kg and (18.62± 4.74)× 106/kg,respectively. The patients' granulocyte count reached ≥ 0.5× 109/L on day＋ 9.6 and＋ 11, platelet count reached ≥ 50× 109/L on day ＋ 12.6 and＋ 21.5 and reticulocyte reached ≥ 0.5％ on day＋ 11.2 and＋ 16.5,respectively,after APBSCT and ABMT. The side effects were mainly the gastrointestinal reactions. Up to now, no relapse were seen but four women had developed secondary amenorrhea after AHSCT. Conclusion： AHSCT is an efficient way for malignant tumors and there were earlier hematopoietic reconstitution and fewer side effects in patient with APBSCT than with ABMT. The impairment of gonad by conditioning may affect the quality of life.
